603669 Stock Overview
Lionco Pharmaceutical Group Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Lionco Pharmaceutical Group Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥4.14 |
| 52 Week High | CN¥6.07 |
| 52 Week Low | CN¥2.94 |
| Beta | 0.25 |
| 1 Month Change | -1.43% |
| 3 Month Change | -12.84% |
| 1 Year Change | -15.68% |
| 3 Year Change | -55.53% |
| 5 Year Change | -32.15% |
| Change since IPO | -32.58% |
Recent News & Updates
Shareholder Returns
| 603669 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 17.6% | -1.1% | -0.4% |
| 1Y | -15.7% | -15.9% | -16.2% |
Return vs Industry: 603669 matched the CN Pharmaceuticals industry which returned -15.9% over the past year.
Return vs Market: 603669 matched the CN Market which returned -16.2% over the past year.
Price Volatility
| 603669 volatility | |
|---|---|
| 603669 Average Weekly Movement | 9.0% |
| Pharmaceuticals Industry Average Movement | 7.9% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 603669's share price has been volatile over the past 3 months.
Volatility Over Time: 603669's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 497 | Ling Ping Tao | www.lingkang.com.cn |
Lionco Pharmaceutical Group Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in China. The company offers nutrition, antimicrobial, antiviral, digestion, cardiovascular, detoxification, anti-tumor, and other products. Lionco Pharmaceutical Group Co., Ltd.
Lionco Pharmaceutical Group Co.,Ltd. Fundamentals Summary
| 603669 fundamental statistics | |
|---|---|
| Market cap | CN¥2.99b |
| Earnings (TTM) | -CN¥144.55m |
| Revenue (TTM) | CN¥200.39m |
14.9x
P/S Ratio-20.7x
P/E RatioIs 603669 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603669 income statement (TTM) | |
|---|---|
| Revenue | CN¥200.39m |
| Cost of Revenue | CN¥110.42m |
| Gross Profit | CN¥89.96m |
| Other Expenses | CN¥234.51m |
| Earnings | -CN¥144.55m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.20 |
| Gross Margin | 44.89% |
| Net Profit Margin | -72.13% |
| Debt/Equity Ratio | 51.2% |
How did 603669 perform over the long term?
See historical performance and comparison